SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-021915
Filing Date
2021-02-12
Accepted
2021-02-12 16:09:36
Documents
2
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE II GP, LLCHEALTHCOR OFFSHORE MASTER FUND, L.P.HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P.HEALTHCOR THERAPEUTICS GP, LLCHEALTHCOR THERAPEUTICS MASTER FU

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216026d1_sc13ga.htm SC 13G/A 188478
2 EXHIBIT 1 tm216026d1_ex99-1.htm EX-99.1 20521
  Complete submission text file 0001104659-21-021915.txt   210962
Mailing Address 55 HUDSON YARDS, 28TH FLOOR NEW YORK NY 10001
Business Address 55 HUDSON YARDS, 28TH FLOOR NEW YORK NY 10001 212-622-7731
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

IRS No.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Subject) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91046 | Film No.: 21627341
SIC: 2834 Pharmaceutical Preparations